S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
Log in

12 Stocks Corporate Insiders are Abandoning in 2021 - 1 of 12

 
Adaptive Biotechnologies (NASDAQ:ADPT)

Dollar Amount of Shares Sold: $242,507,080.65
Number of Insider Stock Sales in the Last 180 Days: 78
Volume of Shares Sold: 4,721,509
Who Sold Shares: Chad M Cohen (CFO), Chad M Robins (CEO), Charles Sang (SVP), Eric Dobmeier (Director), Francis Lo (Insider), Global Investors Lp Viking (Major Shareholder), Harlan S Robins (Insider), Julie Rubinstein (President), Lance Baldo (Insider), Michael J Pellini (Director), Michelle Renee Griffin (Director), Nancy Louise Hill (EVP), Robert Hershberg (Director), Sharon Benzeno (Insider), Stacy L Taylor (SVP) and Susan Bobulsky (SVP)

Insider Trades by Quarter for Adaptive Biotechnologies (NASDAQ:ADPT)

Adaptive Biotechnologies logoAdaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer research questions, as well as to discover new prognostic and diagnostic signals. Read More 





Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.